Press Resease

Skeletal Dysplasia Market - Global Industry Analysis

Skeletal Dysplasia Market: by Type (X-linked Hypophosphatemia, Hypophosphatasia, Achondroplasia, Fibrodysplasia Ossificans Progressive, Multiple Osteochondromas, and Others), and by Treatment (Medication, Surgery, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Published Date: 26-Nov-2019 Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-5090 Status : Published

Global demand for skeletal dysplasia market was valued at USD 2,493.6 in 2018, and is expected to generate revenue of USD 3,303.6 million by end of 2025, growing at a CAGR of 4.1% between 2019 and 2025

Description

According to the report, global demand for skeletal dysplasia market was valued at USD 2,493.6 in 2018, and is expected to generate revenue of USD 3,303.6 million by end of 2025, growing at a CAGR of 4.1% between 2019 and 2025

The report covers forecast and analysis for the global skeletal dysplasia market. The study provides historic data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Million). In-depth secondary research is used to ascertain overall market size, top industry players, top product, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports and other sources have also been considered to arrive at the indicated market numbers.

Global Skeletal Dysplasia Market

A heterogeneous group of more than 450 disorders is knows as skeletal dysplasia is. It encompasses board number of disorders development in cartilage and bone. It has a very wide spectrum and any part of the skeleton can be affected which includes abnormalities the bone shape, size, short stature, and density. Skeletal dysplasia is caused by the disturbance in bone growth during early stage of fetal development.

The study provides a decisive view on the skeletal dysplasia market by segmenting the market based on type, treatment, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The skeletal dysplasia market is segmented on the basis of type into x-linked hypophosphatemia, hypophosphatasia, achondroplasia, fibrodysplasia ossificans progressive, multiple osteochondromas, and others. Hypophosphatasia (HPP) segment held major share of the market in 2018. The growth of this segment is owing to the rising prevalence of the disease. HPP is estimated to be 1 per 300,000 births in Europe.

Medication, surgery, and others are the key treatment segments of the skeletal dysplasia market. The surgery segment dominated the market in terms of revenue in 2018. Growing preference of patients towards surgeries is likely to be one of the major factors responsible for market growth of this segment. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries. Europe held major share of the market for skeletal dysplasia in 2018. High adoption rate of surgeries and rising awareness of this disease are some of the factors responsible for the region’s growth.

The study also includes drivers and restraints for the skeletal dysplasia along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the skeletal dysplasia market on global level. Growing prevalence rate of birth defects and congenital disorders are some of the major factors driving market growth of skeletal dysplasia. As per the stats provided by the Center of Disease Control & Prevention (CDC), 1 in every 33 babies in the U.S. is affected due to birth defects every year. Growing number of genetic disorders is also favoring the growth of skeletal dysplasia market. Rising R&D activities for drug development is also likely to propel market growth. Besides, increasing consumption of alcohol and cigarettes, and lifestyle changes are also among the major factors boosting the market growth of skeletal dysplasia.

The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players within global skeletal dysplasia market include Regeneron, Alexion Pharmaceuticals, Inc., BioMarin, Merck KGaA, Amgen, Inc., and Ipsen Group.

This report segments the global skeletal dysplasia market as follows:

Global Skeletal Dysplasia Market: Type Segment Analysis

  • X-linked Hypophosphatemia
  • Hypophosphatasia
  • Achondroplasia
  • Fibrodysplasia Ossificans Progressive
  • Multiple Osteochondromas
  • Others

Global Skeletal Dysplasia Market: Treatment Segment Analysis

  • Medication
  • Surgery
  • Others

Global Skeletal Dysplasia Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Skeletal Dysplasia Market, 2016 - 2025, (USD Million)
    • 2.2. Skeletal Dysplasia Market: Market Snapshot
  • Chapter 3. Global Skeletal Dysplasia Market - Industry Analysis
    • 3.1. Skeletal Dysplasia Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of skeletal dysplasia
      • 3.2.2. Presence of pipeline products
    • 3.3. Restraints
      • 3.3.1. Lack of awareness
    • 3.4. Opportunity
      • 3.4.1. Increasing unmet medical needs in developing countries
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by type segment
      • 3.6.2. Market attractiveness analysis by treatment segment
      • 3.6.3. Market attractiveness analysis by regional segment
  • Chapter 4. Global Skeletal Dysplasia Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global skeletal dysplasia market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Skeletal Dysplasia Market - Type Segment Analysis
    • 5.1. Global skeletal dysplasia market overview: by type
      • 5.1.1. Global skeletal dysplasia market revenue share, by type, 2018 and 2025
    • 5.2. X-linked Hypophosphatemia
      • 5.2.1. Global skeletal dysplasia market by X-linked hypophosphatemia, 2016 - 2025 (USD Million)
    • 5.3. Hypophosphatasia
      • 5.3.1. Global skeletal dysplasia market by hypophosphatasia, 2016 - 2025 (USD Million)
    • 5.4. Achondroplasia
      • 5.4.1. Global skeletal dysplasia market by achondroplasia, 2016 - 2025 (USD Million)
    • 5.5. Fibrodysplasia Ossificans Progressive
      • 5.5.1. Global skeletal dysplasia market by fibrodysplasia ossificans progressive, 2016 - 2025 (USD Million)
    • 5.6. Multiple Osteochondromas
      • 5.6.1. Global skeletal dysplasia market by multiple osteochondromas, 2016 - 2025 (USD Million)
    • 5.7. Others
      • 5.7.1. Global skeletal dysplasia market by others 2016 - 2025 (USD Million)
  • Chapter 6. Global Skeletal Dysplasia Market - Treatment Segment Analysis
    • 6.1. Global skeletal dysplasia market overview: by treatment
      • 6.1.1. Global skeletal dysplasia market revenue share, by treatment, 2018 and 2025
    • 6.2. Medication
      • 6.2.1. Global skeletal dysplasia market by medication, 2016 - 2025 (USD Million)
    • 6.3. Surgery
      • 6.3.1. Global skeletal dysplasia market by surgery, 2016 - 2025 (USD Million)
    • 6.4. Others
      • 6.4.1. Global skeletal dysplasia market by others, 2016 - 2025 (USD Million)
  • Chapter 7. Global Skeletal Dysplasia Market - Regional Analysis
    • 7.1. Global skeletal dysplasia market overview: by region
      • 7.1.1. Global skeletal dysplasia market revenue share, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America skeletal dysplasia market, by country, 2019 - 2025 (USD Million)
      • 7.2.2. North America skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
      • 7.2.3. North America skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.2.4. The U.S.
      • 7.2.4.1. The U.S. skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
      • 7.2.4.2. The U.S. skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.2.5. Rest of North America
      • 7.2.5.1. Rest of North America skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
      • 7.2.5.2. Rest of North America skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe skeletal dysplasia market, by country, 2019 - 2025 (USD Million)
      • 7.3.2. Europe skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
      • 7.3.3. Europe skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.3.4. U.K.
        • 7.3.4.1. U.K. skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.3.4.2. U.K. skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.3.5.2. France skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.3.6.2. Germany skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.3.7.2. Rest of Europe skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific skeletal dysplasia market, by country, 2019 - 2025 (USD Million)
      • 7.4.2. Asia Pacific skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
      • 7.4.3. Asia Pacific skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.4.4.2. China skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.4.5.2. Japan skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.4.6.2. India skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America skeletal dysplasia market, by country, 2019 - 2025 (USD Million)
      • 7.5.2. Latin America skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
      • 7.5.3. Latin America skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.5.4.2. Brazil skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
        • 7.5.5.2. Rest of Latin America skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa skeletal dysplasia market, 2019 - 2025 (USD Million)
      • 7.6.2. Middle East & Africa skeletal dysplasia market revenue, by type, 2019 - 2025 (USD Million)
      • 7.6.3. Middle East & Africa skeletal dysplasia market revenue, by treatment, 2019 - 2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Alexion Pharmaceuticals, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Ipsen Group
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Merck KGaA
    • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. BioMarin
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Amgen, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. Regeneron
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social